Latest Headlines

  1. Opentrons Accelerates The Enablement Of AI-Based Laboratory Robotics With NVIDIA 2/5/2026

    Opentrons Labworks Inc., a laboratory robotics company enabling AI-driven autonomous science, is accelerating the development and deployment of physical AI-enabled laboratory robotics with NVIDIA.

  2. Hims & Hers Launches Multi-Cancer Early Detection Testing, Connecting Customers To Cutting-Edge Proactive Care 2/4/2026

    Today, Hims & Hers Health, Inc. the leading digital health and wellness platform, launched access to the Hims & Hers Multi-Cancer Test by Galleri, a simple cancer screening blood test that can detect a signal for 50+ types of cancer even before symptoms appear1.

  3. analytica Conference 2026: From Diagnosing Leukemia To Detecting Opioids 2/4/2026

    Under the motto “Science meets industry”, the analytica conference covers the broad spectrum of analytical chemistry and bioanalytics. From March 24 to 26, researchers from all over the world will present their latest findings in Munich, at the same time as analytica, the world’s leading trade fair for laboratory technology, analysis and biotechnology.​

  4. Co-Diagnostics JV, CoSara, Receives ISO 13485 Certification In Preparation For Manufacturing Upcoming PCR Platform 2/4/2026

    Co-Diagnostics, Inc. (OTC: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that CoSara Diagnostics Pvt. Ltd. ("CoSara"), the joint venture between Co-Dx and Ambalal Sarabhai Enterprises Limited (ASE Group), has successfully completed the necessary audits of its quality management system ("QMS") and that its manufacturing facility located in Vadodara, India, has been granted ISO 13485:2016 certification.

  5. Rarity Bioscience Announces That ARUP Laboratories Has Become The First U.S. Reference Lab To Validate Its Ultrasensitive superRCA Assay 2/3/2026

    Sweden-based Rarity Bioscience today announced that ARUP Laboratories, a leading national reference laboratory and nonprofit enterprise of the University of Utah and its Department of Pathology, has become the first commercial laboratory in the United States to validate and offer its groundbreaking superRCA assay for research applications.

  6. QIAGEN Showcases QIAsprint Connect High-Throughput Automation System For Labs Worldwide At SLAS 2026 2/3/2026

    QIAGEN N.V. today announced the first public showcase of QIAsprint Connect at SLAS 2026 in Boston, marking QIAGEN’s entry into high-throughput benchtop automation for sample processing in research laboratories.

  7. Ambry Genetics Announces One Millionth Test Leveraging RNA To Improve Diagnostic Accuracy And Yield 2/2/2026

    Ambry Genetics, a leader in clinical genomic testing, and now a wholly owned subsidiary of Tempus AI, Inc. announced the completion of its one-millionth DNA/RNA test, underscoring the company’s commitment to diagnostic accuracy.

  8. Aiforia Releases A New CE-IVD Marked AI Solution For Gastric Cancer Diagnostics 2/2/2026

    Aiforia Technologies Plc today announced the launch of a new clinical AI solution for gastric cancer diagnostics. This solution is CE-IVD marked under the IVDR. Aiforia Gastric Cancer AI application is designed to support pathologists in the detection and reporting of gastric cancer in digitized gastric tissue samples.

  9. Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test For Myeloma, Enabling Ultrasensitive Detection Of Residual Disease 2/2/2026
  10. Lumea And Voicebrook Announce Strategic Partnership To Advance Digital Pathology Workflows 1/30/2026

    Lumea, the leading provider of innovative tissue handling and digital diagnostic technologies, today announced a strategic digital pathology partnership with Voicebrook, the leading provider of pathology reporting solutions.